Quick Links

type 1 diabetes Tag

The UW Medicine Diabetes Institute is the proud home of the COVERED Registry. COVERED stands for Community of Volunteers Engaged in Research to End Diabetes. The goal of this patient registry is to connect people interested in diabetes care with researchers studying diabetes and other...

Patients ages 8 – 17 with newly diagnosed type 1 diabetes have an opportunity to participate in the PROTECT Study, a clinical trial to see if a study drug called teplizumab can safely preserve insulin-producing cells. Previous clinical studies have suggested a benefit of teplizumab in...

We are recruiting Seattle-area adults to test whether two drugs, liraglutide and golimumab, can temporarily “wake-up” beta-cells in type 1 diabetes patients with longstanding diabetes. Participant Eligibility You may be eligible if you: • were diagnosed with type 1 diabetes at least three years ago • are age 18 through 50 • live...

[box class="summary"][/box]We are inviting you to participate in a research study to help us improve our understanding of diabetes and immune mediated diseases. The study consists of a computer registry where we store your contact, research, and health information, and a sample repository where we...

SITE PARTNERS
uw-footer